Literature DB >> 8964739

Interaction between clenbuterol and run training: effects on exercise performance and MLC isoform content.

C P Ingalls1, W S Barnes, S B Smith.   

Abstract

The purpose of this study was to determine the separate and combined effects of clenbuterol (CB) administration and interval training on running performance and myosin light-chain (MLC) isoform expression in mouse skeletal muscle. Mice were randomly assigned to one of four treatment groups: 1) control (Con), 2) exercise (Ex), 3) drug (CB), or 4) exercise + drug (Ex + CB). CB and Ex + CB mice were given CB (1.6 mg/kg) orally 4 days/wk. Ex and Ex + CB mice were trained 4 days/wk on a motorized treadmill (3 sets of 3 min, 36-40 m/min, 10-17% grade, 30-s recovery). After 8 wk of treatment, exercise conditioning increased total work performed 58% in the Ex group during a run-to-exhaustion treadmill test, whereas CB decreased total work by 25% in the CB group; in combination with exercise training, CB treatment eliminated the Ex-induced increase in work. Polyacrylamide gel electrophoresis indicated that run training, CB treatment, or a combination did not (P > 0.01) promote changes in fast and slow MLC isoforms in the soleus, gastrocnemius, or tibialis anterior muscles. Although not different from each other after 8 wk, CB and Ex + CB treatments produced significantly greater values than Con and Ex for the following variables: muscle mass (17-46%), total protein (22-50%), and myofibrillar protein (19-53%). It was concluded that CB decreases exercise performance and that the combination of Ex and CB have antagonistic effects on running performance; the two treatments do not interact to diminish the anabolic effects of CB on skeletal muscle and do not alter MLC isoform profiles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964739     DOI: 10.1152/jappl.1996.80.3.795

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  14 in total

Review 1.  The rush to adrenaline: drugs in sport acting on the beta-adrenergic system.

Authors:  E Davis; R Loiacono; R J Summers
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

2.  Grip force, EDL contractile properties, and voluntary wheel running after postdevelopmental myostatin depletion in mice.

Authors:  Kirkwood E Personius; Aditi Jayaram; David Krull; Roger Brown; Tianshun Xu; Bajin Han; Kerri Burgess; Christopher Storey; Bharati Shah; Rabi Tawil; Stephen Welle
Journal:  J Appl Physiol (1985)       Date:  2010-07-01

3.  Therapeutic clenbuterol treatment does not alter Ca2+ sensitivity of permeabilized fast muscle fibres from exercise trained or untrained horses.

Authors:  David R Plant; Charles F Kearns; Kenneth H McKeever; Gordon S Lynch
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

4.  Adaptive changes of Myosin isoforms in response to long-term strength and power training in middle-aged men.

Authors:  Raivo Puhke; Sirkka Aunola; Pirjo Ailanto; Karin Alev; Mika Venojärvi; Heikki Rusko; Teet Seene
Journal:  J Sports Sci Med       Date:  2006-06-01       Impact factor: 2.988

5.  Chronic β2 -adrenoceptor agonist treatment alters muscle proteome and functional adaptations induced by high intensity training in young men.

Authors:  Morten Hostrup; Johan Onslev; Glenn A Jacobson; Richard Wilson; Jens Bangsbo
Journal:  J Physiol       Date:  2017-11-12       Impact factor: 5.182

6.  Dose-dependent apoptotic and necrotic myocyte death induced by the beta2-adrenergic receptor agonist, clenbuterol.

Authors:  Jatin G Burniston; Neil Chester; William A Clark; Lip-Bun Tan; David F Goldspink
Journal:  Muscle Nerve       Date:  2005-12       Impact factor: 3.217

7.  Anabolic effects of a non-myotoxic dose of the beta2-adrenergic receptor agonist clenbuterol on rat plantaris muscle.

Authors:  Jatin G Burniston; Lynn McLean; Robert J Beynon; David F Goldspink
Journal:  Muscle Nerve       Date:  2007-02       Impact factor: 3.217

8.  Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles.

Authors:  Jatin G Burniston; William A Clark; Lip-Bun Tan; David F Goldspink
Journal:  Muscle Nerve       Date:  2006-05       Impact factor: 3.217

9.  Necrotic Effect versus Apoptotic Nature of Camptothecin in Human Cervical Cancer Cells.

Authors:  Abbas Zare-Mirakabadi; Ali Sarzaeem; Saeed Moradhaseli; Aida Sayad; Masoud Negahdary
Journal:  Iran J Cancer Prev       Date:  2012

10.  Effects of chronic administration of clenbuterol on contractile properties and calcium homeostasis in rat extensor digitorum longus muscle.

Authors:  Pascal Sirvent; Aymerick Douillard; Olivier Galbes; Christelle Ramonatxo; Guillaume Py; Robin Candau; Alain Lacampagne
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.